172 related articles for article (PubMed ID: 12538731)
1. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia.
Buzello M; Törnig J; Faulhaber J; Ehmke H; Ritz E; Amann K
J Am Soc Nephrol; 2003 Feb; 14(2):311-6. PubMed ID: 12538731
[TBL] [Abstract][Full Text] [Related]
2. No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy.
Buzello M; Haas CS; Hauptmann F; Gross ML; Faulhaber J; Schultze-Mosgau S; Ehmke H; Ritz E; Amann K
Nephrol Dial Transplant; 2004 Mar; 19(3):566-73. PubMed ID: 14767010
[TBL] [Abstract][Full Text] [Related]
3. Calcification of the cavernosal bodies may be responsible for development of erectile dysfunction in uremic apolipoprotein E deficient (apoE-/-) mice.
Ivanovski O; Nikolov IG; Davceva O; Petrushevska G
Rev Int Androl; 2021; 19(1):25-33. PubMed ID: 31899189
[TBL] [Abstract][Full Text] [Related]
4. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
5. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
6. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
[TBL] [Abstract][Full Text] [Related]
7. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice.
Becker LE; Koleganova N; Piecha G; Noronha IL; Zeier M; Geldyyev A; Kökeny G; Ritz E; Gross ML
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F772-82. PubMed ID: 21159735
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
9. Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.
Arend N; Hilgers KF; Campean V; Karpe B; Cordasic N; Klanke B; Amann K
PLoS One; 2014; 9(2):e88601. PubMed ID: 24586350
[TBL] [Abstract][Full Text] [Related]
10. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
Bro S; Bentzon JF; Falk E; Andersen CB; Olgaard K; Nielsen LB
J Am Soc Nephrol; 2003 Oct; 14(10):2466-74. PubMed ID: 14514724
[TBL] [Abstract][Full Text] [Related]
11. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
[TBL] [Abstract][Full Text] [Related]
12. Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice.
Carneiro SS; Carminati RZ; Freitas FP; Podratz PL; Balarini CM; Graceli JB; Meyrelles SS; Vasquez EC; Gava AL
Lipids Health Dis; 2014 Nov; 13():176. PubMed ID: 25422135
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
Nogueira BV; Peotta VA; Meyrelles SS; Vasquez EC
Arch Med Res; 2007 Nov; 38(8):816-21. PubMed ID: 17923260
[TBL] [Abstract][Full Text] [Related]
14. The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice.
Gut N; Piecha G; Pradel A; Geldyyev A; Potemkina A; Ritz E; Regele H; Schmitt CP; Gross-Weissmann ML
Am J Physiol Renal Physiol; 2013 Aug; 305(3):F277-85. PubMed ID: 23698122
[TBL] [Abstract][Full Text] [Related]
15. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
16. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.
Grimsditch DC; Penfold S; Latcham J; Vidgeon-Hart M; Groot PH; Benson GM
Atherosclerosis; 2000 Aug; 151(2):389-97. PubMed ID: 10924715
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension.
Arruda RM; Peotta VA; Meyrelles SS; Vasquez EC
Hypertension; 2005 Oct; 46(4):932-6. PubMed ID: 16087779
[TBL] [Abstract][Full Text] [Related]
18. Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells.
Shen Y; Yuan Z; Yin A; Liu Y; Xiao Y; Wu Y; Wang L; Liang X; Zhao Y; Tian Y; Liu W; Chen T; Kishimoto C
Atherosclerosis; 2011 Oct; 218(2):330-8. PubMed ID: 21868013
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress after uninephrectomy alters heart morphology in the apolipoprotein E -/- mouse.
Piecha G; Koleganova N; Gross ML; Geldyyev A; Ritz E
J Hypertens; 2008 Nov; 26(11):2220-9. PubMed ID: 18854764
[TBL] [Abstract][Full Text] [Related]
20. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.
Amann K; Törnig J; Kugel B; Gross ML; Tyralla K; El-Shakmak A; Szabo A; Ritz E
Kidney Int; 2003 Apr; 63(4):1296-301. PubMed ID: 12631346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
